Cargando…
Validation of the Reflux Symptom Questionnaire Electronic Diary in Partial Responders to Proton Pump Inhibitor Therapy
OBJECTIVES: We aimed to develop and validate the Reflux Symptom Questionnaire electronic Diary (RESQ-eD) for use in clinical trials in patients with a partial response to proton pump inhibitor (PPI) therapy, using methods that meet US Food & Drug Administration (FDA) regulatory standards. METHOD...
Autores principales: | Vakil, Nimish, Björck, Karin, Denison, Hans, Halling, Katarina, Karlsson, Maria, Paty, Jean, Silberg, Debra G, Rydén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365670/ https://www.ncbi.nlm.nih.gov/pubmed/23238029 http://dx.doi.org/10.1038/ctg.2012.1 |
Ejemplares similares
-
Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations
por: Vakil, Nimish, et al.
Publicado: (2014) -
Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study
por: Katzka, David A, et al.
Publicado: (2017) -
Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis
por: Allott, Emma H, et al.
Publicado: (2012) -
Withdrawing PPI Therapy After Healing Esophagitis Does Not Worsen Symptoms or Cause Persistent Hypergastrinemia: Analysis of Dexlansoprazole MR Clinical Trial Data
por: Metz, David C, et al.
Publicado: (2011) -
Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis
por: Greer, K B, et al.
Publicado: (2013)